BMY vs TIL · P/E 17, rev $48.19B vs $51.3M cap
Bristol-Myers Squibb Company (BMY) versus Instil Bio Inc. (TIL) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Instil Bio Inc. (TIL) is a biotechnology company listed on NASDAQ.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
TIL does not have a complete income-statement cache yet.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. TIL currently screens at market cap $51.3M.
Not investment advice. Open the BMY and TIL stock pages for the full models.
Not investment advice.